{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T09:32:11Z","timestamp":1761989531314,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Indian Journal of Medical Microbiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.ijmmb.2020.09.003","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T12:39:42Z","timestamp":1605530382000},"page":"59-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigation of isepamicin in-vitro efficiency in Gram negative bacteria"],"prefix":"10.1016","volume":"39","author":[{"given":"Tanriverdi Cayci","family":"Yeliz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hosseini Baghanam","family":"Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Al-Furais","family":"Sarah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nay","family":"Sreylis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hacieminoglu Ulker","family":"Kubra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birinci","family":"Asuman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijmmb.2020.09.003_bib1","first-page":"31","article-title":"The changing nature of aminoglycoside resistance mechanisms and the role of isepamicin a new broad-spectrum aminoglycoside. The Aminoglycoside Resistance Study Groups","volume":"7","author":"Miller","year":"1995","journal-title":"J\u00a0XChemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/clinids\/24.Supplement_1.S46","article-title":"The most frequent aminoglycoside resistance mechanisms--changes with time and geographic area: a reflection of aminoglycoside usage patterns? Aminoglycoside Resistance Study Groups","volume":"24","author":"Miller","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.jmii.2015.07.010","article-title":"In vitro activity of aminoglycosides against clinical isolates of Acinetobacter baumannii complex and other nonfermentative Gram-negative bacilli causing healthcare-associated bloodstream infections in Taiwan","volume":"49","author":"Liu","year":"2016","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib4","first-page":"329","article-title":"In vivo analysis of structure-activity relationships among four aminoglycosides: gentamicin, netilmicin, 1-N HAPA gentamicin B and amikacin","volume":"26","author":"Goering","year":"1979","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.7164\/antibiotics.31.681","article-title":"The syntheses and biological properties of 1-N-(S-4-amino-2-hydroxybutyryl)-gentamicin B and 1-N-(S-3-amino-2-hydroxypropionyl)-gentamicin B","volume":"31","author":"Nagabhushan","year":"1978","journal-title":"The J of Antibio"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib6","first-page":"201","article-title":"Experimental and clinical studies of HAPA-B","volume":"33","author":"Oshitani","year":"1985","journal-title":"Chemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000276162","article-title":"Effect of dosing schedule on aminoglycoside ototoxicity: comparative cochlear ototoxicity of amikacin and isepamicin","volume":"52","author":"Takumida","year":"1990","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib8","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1046\/j.1198-743x.2001.00284.x","article-title":"The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey","volume":"7","author":"Over","year":"2001","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib9","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/mdr.2005.11.330","article-title":"In vitro activities of tigecycline, ertapenem, isepamicin, and other antimicrobial agents against clinically isolated organisms in Taiwan","volume":"11","author":"Cheng","year":"2005","journal-title":"Microb Drug Resist"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib10","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1128\/AAC.06358-11","article-title":"In vitro antimicrobial susceptibility to isepamicin of 6,296 Enterobacteriaceae clinical isolates collected at a tertiary care university hospital in Greece","volume":"56","author":"Maraki S Samonis","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib11","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1086\/429323","article-title":"Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections","volume":"40","author":"Falagas","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"author":"European Committee on Antimicrobial Susceptibility Testing","key":"10.1016\/j.ijmmb.2020.09.003_bib13"},{"year":"2010","series-title":"Comit\u00e9 de l'Antibiogramme de la Soci\u00e9t\u00e9 Fran\u00e7aise de Microbiologie. Recommandations 2010","author":"Bonnet","key":"10.1016\/j.ijmmb.2020.09.003_bib14"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0891-5520(20)30753-4","article-title":"Epidemiology and clinical impact of gram-negative sepsis","volume":"5","author":"Martin","year":"1991","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib16","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1093\/clinids\/5.4.629","article-title":"Analysis of 1,186 episodes of gram-negative bacteremia in non-university hospitals: the effects of antimicrobial therapy","volume":"5","author":"Bryan","year":"1983","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib17","first-page":"481","article-title":"In vitro activity of isepamicin and other aminoglycosides against clinical isolates of Gram-negative bacteria causing nosocomial bloodstream infections","volume":"40","author":"Tsai","year":"2007","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib18","first-page":"47","article-title":"Once-daily versus multiple-daily dosing of aminoglycosides","volume":"7","author":"Craig","year":"1995","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib19","first-page":"1","article-title":"Antibiotics: action and resistance in gram-negative bacteria","volume":"35","author":"Siu","year":"2002","journal-title":"J\u00a0Microbiol Immunol Infect"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.1472-8206.2001.00020.x","article-title":"Comparison of two methods to obtain a desired first isepamicin peak in intensive care patients","volume":"15","author":"Fauvelle","year":"2001","journal-title":"Fundamental & Clinical Pharmacology"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib21","first-page":"7","article-title":"Isepamicin (SCH 21420, 1-N-HAPA gentamicin B): microbiological characteristics including antimicrobial potency of spectrum of activity","volume":"7","author":"Jones","year":"1995","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib22","doi-asserted-by":"crossref","first-page":"688","DOI":"10.7164\/antibiotics.31.688","article-title":"Biological activity of SCH 21420, the 1-N-S-alpha-hydroxy-beta-aminopropionyl derivativeof gentamicin B","volume":"31","author":"Miller","year":"1978","journal-title":"J\u00a0Antibiot"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.5152\/kd.2018.13","article-title":"Investigation of isepamicin, chloramphenicol and minocycline sensitivity in carbapenem-resistant Enterobacteriaceae","volume":"31","author":"Karakulluk\u00e7u","year":"2018","journal-title":"Klimik Derg"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib24","first-page":"21","article-title":"Resistance to isepamicin, amikacin and gentamicin in gram-negative bacteria","volume":"21","author":"K\u00fc\u00e7\u00fckate\u015f","year":"2007","journal-title":"\u0130nfeks Derg"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1179\/acb.2001.045","article-title":"Comparative in vitro activity of isepamicin and other antibiotics against gram negative bacilli from intensive care units (ICU) in Belgium","volume":"56","author":"Belgian Isepamicin Multicenter Study Group","year":"2001","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/jac\/44.4.483","article-title":"Aminoglycoside resistance in gram-negative blood isolates from various hospitals in Belgium and the grand duchy of Luxembourg. Aminoglycoside resistance study group","volume":"44","author":"Vanhoof","year":"1999","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijmmb.2020.09.003_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1128\/AAC.43.4.727","article-title":"Aminoglycosides: activity and resistance","volume":"43","author":"Mingeot-Leclercq","year":"1999","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Indian Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0255085720300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T19:18:47Z","timestamp":1759346327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0255085720300037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0255085720300037"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmmb.2020.09.003","relation":{},"ISSN":["0255-0857"],"issn-type":[{"type":"print","value":"0255-0857"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Investigation of isepamicin in-vitro efficiency in Gram negative bacteria","name":"articletitle","label":"Article Title"},{"value":"Indian Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmmb.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian Association of Medical Microbiologists. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}